The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Piperlongumine Market Research Report 2024
Synopsis
Piperlongumine, a natural alkaloid found in Piper longum L., a pepper plant, can increase the level of reactive oxygen species (ROS) and selectively kill cancer cells. It is also a direct inhibitor of TrxR1 and has inhibitory activity on gastric cancer; A new CRM1 inhibitor; It can inhibit PI3K/Akt/mTOR in human breast cancer cells.
The global Piperlongumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Piperlongumine is a known ROS inducer, which can induce cell death of pancreatic cancer cells. As a thromboxane A (2) receptor antagonist, it inhibits platelet aggregation. Piperlongumine can also promote autophagy by inhibiting Akt/mTOR signaling pathway and mediate tumor cell death.Piperlongumine has anti-inflammatory, antibacterial, anti angiogenesis, antioxidant, anti-tumor and anti diabetes activities. In tumor cells, Piperlongumine can induce ROS and apoptosis. Piperlongumine has anti myocardial fibrosis effects, and inhibits the transformation of myofibroblasts by inhibiting ERK1/2 signaling pathway.
This report aims to provide a comprehensive presentation of the global market for Piperlongumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piperlongumine.
Report Scope
The Piperlongumine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Piperlongumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piperlongumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Didu
Aikon
YuanYe
TargetMol
Bide Pharmatech
Macklin
Solarbio
DaoLan
Beijing Jingming
Shanghai Xianding
Chengdu Gechun
Shanghai AcmecBiochemical
Cool Pharm
GLR Innovations
ABCR GmBH
Chem-Impex International
Cayman Chemical
Apollo Scientific
Matrix Scientific
Tocris Bioscience
Axon Medchem
Dalton Research Molecules
ChemScene
CSNpharm
Segment by Type
95% Purity
97% Purity
98% Purity
Segment by Application
Medical
Health Products
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piperlongumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piperlongumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Piperlongumine, a natural alkaloid found in Piper longum L., a pepper plant, can increase the level of reactive oxygen species (ROS) and selectively kill cancer cells. It is also a direct inhibitor of TrxR1 and has inhibitory activity on gastric cancer; A new CRM1 inhibitor; It can inhibit PI3K/Akt/mTOR in human breast cancer cells.
The global Piperlongumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Piperlongumine is a known ROS inducer, which can induce cell death of pancreatic cancer cells. As a thromboxane A (2) receptor antagonist, it inhibits platelet aggregation. Piperlongumine can also promote autophagy by inhibiting Akt/mTOR signaling pathway and mediate tumor cell death.Piperlongumine has anti-inflammatory, antibacterial, anti angiogenesis, antioxidant, anti-tumor and anti diabetes activities. In tumor cells, Piperlongumine can induce ROS and apoptosis. Piperlongumine has anti myocardial fibrosis effects, and inhibits the transformation of myofibroblasts by inhibiting ERK1/2 signaling pathway.
This report aims to provide a comprehensive presentation of the global market for Piperlongumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piperlongumine.
Report Scope
The Piperlongumine market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Piperlongumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piperlongumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Didu
Aikon
YuanYe
TargetMol
Bide Pharmatech
Macklin
Solarbio
DaoLan
Beijing Jingming
Shanghai Xianding
Chengdu Gechun
Shanghai AcmecBiochemical
Cool Pharm
GLR Innovations
ABCR GmBH
Chem-Impex International
Cayman Chemical
Apollo Scientific
Matrix Scientific
Tocris Bioscience
Axon Medchem
Dalton Research Molecules
ChemScene
CSNpharm
Segment by Type
95% Purity
97% Purity
98% Purity
Segment by Application
Medical
Health Products
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piperlongumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piperlongumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Piperlongumine Market Overview
1.1 Product Overview and Scope of Piperlongumine
1.2 Piperlongumine Segment by Type
1.2.1 Global Piperlongumine Market Value Comparison by Type (2024-2030)
1.2.2 95% Purity
1.2.3 97% Purity
1.2.4 98% Purity
1.3 Piperlongumine Segment by Application
1.3.1 Global Piperlongumine Market Value by Application: (2024-2030)
1.3.2 Medical
1.3.3 Health Products
1.4 Global Piperlongumine Market Size Estimates and Forecasts
1.4.1 Global Piperlongumine Revenue 2019-2030
1.4.2 Global Piperlongumine Sales 2019-2030
1.4.3 Global Piperlongumine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Piperlongumine Market Competition by Manufacturers
2.1 Global Piperlongumine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Piperlongumine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Piperlongumine Average Price by Manufacturers (2019-2024)
2.4 Global Piperlongumine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Piperlongumine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piperlongumine, Product Type & Application
2.7 Piperlongumine Market Competitive Situation and Trends
2.7.1 Piperlongumine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Piperlongumine Players Market Share by Revenue
2.7.3 Global Piperlongumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piperlongumine Retrospective Market Scenario by Region
3.1 Global Piperlongumine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Piperlongumine Global Piperlongumine Sales by Region: 2019-2030
3.2.1 Global Piperlongumine Sales by Region: 2019-2024
3.2.2 Global Piperlongumine Sales by Region: 2025-2030
3.3 Global Piperlongumine Global Piperlongumine Revenue by Region: 2019-2030
3.3.1 Global Piperlongumine Revenue by Region: 2019-2024
3.3.2 Global Piperlongumine Revenue by Region: 2025-2030
3.4 North America Piperlongumine Market Facts & Figures by Country
3.4.1 North America Piperlongumine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Piperlongumine Sales by Country (2019-2030)
3.4.3 North America Piperlongumine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piperlongumine Market Facts & Figures by Country
3.5.1 Europe Piperlongumine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Piperlongumine Sales by Country (2019-2030)
3.5.3 Europe Piperlongumine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piperlongumine Market Facts & Figures by Country
3.6.1 Asia Pacific Piperlongumine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Piperlongumine Sales by Country (2019-2030)
3.6.3 Asia Pacific Piperlongumine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piperlongumine Market Facts & Figures by Country
3.7.1 Latin America Piperlongumine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Piperlongumine Sales by Country (2019-2030)
3.7.3 Latin America Piperlongumine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Piperlongumine Market Facts & Figures by Country
3.8.1 Middle East and Africa Piperlongumine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Piperlongumine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Piperlongumine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piperlongumine Sales by Type (2019-2030)
4.1.1 Global Piperlongumine Sales by Type (2019-2024)
4.1.2 Global Piperlongumine Sales by Type (2025-2030)
4.1.3 Global Piperlongumine Sales Market Share by Type (2019-2030)
4.2 Global Piperlongumine Revenue by Type (2019-2030)
4.2.1 Global Piperlongumine Revenue by Type (2019-2024)
4.2.2 Global Piperlongumine Revenue by Type (2025-2030)
4.2.3 Global Piperlongumine Revenue Market Share by Type (2019-2030)
4.3 Global Piperlongumine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Piperlongumine Sales by Application (2019-2030)
5.1.1 Global Piperlongumine Sales by Application (2019-2024)
5.1.2 Global Piperlongumine Sales by Application (2025-2030)
5.1.3 Global Piperlongumine Sales Market Share by Application (2019-2030)
5.2 Global Piperlongumine Revenue by Application (2019-2030)
5.2.1 Global Piperlongumine Revenue by Application (2019-2024)
5.2.2 Global Piperlongumine Revenue by Application (2025-2030)
5.2.3 Global Piperlongumine Revenue Market Share by Application (2019-2030)
5.3 Global Piperlongumine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Didu
6.1.1 Didu Corporation Information
6.1.2 Didu Description and Business Overview
6.1.3 Didu Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Didu Piperlongumine Product Portfolio
6.1.5 Didu Recent Developments/Updates
6.2 Aikon
6.2.1 Aikon Corporation Information
6.2.2 Aikon Description and Business Overview
6.2.3 Aikon Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aikon Piperlongumine Product Portfolio
6.2.5 Aikon Recent Developments/Updates
6.3 YuanYe
6.3.1 YuanYe Corporation Information
6.3.2 YuanYe Description and Business Overview
6.3.3 YuanYe Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 YuanYe Piperlongumine Product Portfolio
6.3.5 YuanYe Recent Developments/Updates
6.4 TargetMol
6.4.1 TargetMol Corporation Information
6.4.2 TargetMol Description and Business Overview
6.4.3 TargetMol Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TargetMol Piperlongumine Product Portfolio
6.4.5 TargetMol Recent Developments/Updates
6.5 Bide Pharmatech
6.5.1 Bide Pharmatech Corporation Information
6.5.2 Bide Pharmatech Description and Business Overview
6.5.3 Bide Pharmatech Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bide Pharmatech Piperlongumine Product Portfolio
6.5.5 Bide Pharmatech Recent Developments/Updates
6.6 Macklin
6.6.1 Macklin Corporation Information
6.6.2 Macklin Description and Business Overview
6.6.3 Macklin Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Macklin Piperlongumine Product Portfolio
6.6.5 Macklin Recent Developments/Updates
6.7 Solarbio
6.6.1 Solarbio Corporation Information
6.6.2 Solarbio Description and Business Overview
6.6.3 Solarbio Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Solarbio Piperlongumine Product Portfolio
6.7.5 Solarbio Recent Developments/Updates
6.8 DaoLan
6.8.1 DaoLan Corporation Information
6.8.2 DaoLan Description and Business Overview
6.8.3 DaoLan Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DaoLan Piperlongumine Product Portfolio
6.8.5 DaoLan Recent Developments/Updates
6.9 Beijing Jingming
6.9.1 Beijing Jingming Corporation Information
6.9.2 Beijing Jingming Description and Business Overview
6.9.3 Beijing Jingming Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Jingming Piperlongumine Product Portfolio
6.9.5 Beijing Jingming Recent Developments/Updates
6.10 Shanghai Xianding
6.10.1 Shanghai Xianding Corporation Information
6.10.2 Shanghai Xianding Description and Business Overview
6.10.3 Shanghai Xianding Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Xianding Piperlongumine Product Portfolio
6.10.5 Shanghai Xianding Recent Developments/Updates
6.11 Chengdu Gechun
6.11.1 Chengdu Gechun Corporation Information
6.11.2 Chengdu Gechun Piperlongumine Description and Business Overview
6.11.3 Chengdu Gechun Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chengdu Gechun Piperlongumine Product Portfolio
6.11.5 Chengdu Gechun Recent Developments/Updates
6.12 Shanghai AcmecBiochemical
6.12.1 Shanghai AcmecBiochemical Corporation Information
6.12.2 Shanghai AcmecBiochemical Piperlongumine Description and Business Overview
6.12.3 Shanghai AcmecBiochemical Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai AcmecBiochemical Piperlongumine Product Portfolio
6.12.5 Shanghai AcmecBiochemical Recent Developments/Updates
6.13 Cool Pharm
6.13.1 Cool Pharm Corporation Information
6.13.2 Cool Pharm Piperlongumine Description and Business Overview
6.13.3 Cool Pharm Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cool Pharm Piperlongumine Product Portfolio
6.13.5 Cool Pharm Recent Developments/Updates
6.14 GLR Innovations
6.14.1 GLR Innovations Corporation Information
6.14.2 GLR Innovations Piperlongumine Description and Business Overview
6.14.3 GLR Innovations Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 GLR Innovations Piperlongumine Product Portfolio
6.14.5 GLR Innovations Recent Developments/Updates
6.15 ABCR GmBH
6.15.1 ABCR GmBH Corporation Information
6.15.2 ABCR GmBH Piperlongumine Description and Business Overview
6.15.3 ABCR GmBH Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ABCR GmBH Piperlongumine Product Portfolio
6.15.5 ABCR GmBH Recent Developments/Updates
6.16 Chem-Impex International
6.16.1 Chem-Impex International Corporation Information
6.16.2 Chem-Impex International Piperlongumine Description and Business Overview
6.16.3 Chem-Impex International Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chem-Impex International Piperlongumine Product Portfolio
6.16.5 Chem-Impex International Recent Developments/Updates
6.17 Cayman Chemical
6.17.1 Cayman Chemical Corporation Information
6.17.2 Cayman Chemical Piperlongumine Description and Business Overview
6.17.3 Cayman Chemical Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Cayman Chemical Piperlongumine Product Portfolio
6.17.5 Cayman Chemical Recent Developments/Updates
6.18 Apollo Scientific
6.18.1 Apollo Scientific Corporation Information
6.18.2 Apollo Scientific Piperlongumine Description and Business Overview
6.18.3 Apollo Scientific Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Apollo Scientific Piperlongumine Product Portfolio
6.18.5 Apollo Scientific Recent Developments/Updates
6.19 Matrix Scientific
6.19.1 Matrix Scientific Corporation Information
6.19.2 Matrix Scientific Piperlongumine Description and Business Overview
6.19.3 Matrix Scientific Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Matrix Scientific Piperlongumine Product Portfolio
6.19.5 Matrix Scientific Recent Developments/Updates
6.20 Tocris Bioscience
6.20.1 Tocris Bioscience Corporation Information
6.20.2 Tocris Bioscience Piperlongumine Description and Business Overview
6.20.3 Tocris Bioscience Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Tocris Bioscience Piperlongumine Product Portfolio
6.20.5 Tocris Bioscience Recent Developments/Updates
6.21 Axon Medchem
6.21.1 Axon Medchem Corporation Information
6.21.2 Axon Medchem Piperlongumine Description and Business Overview
6.21.3 Axon Medchem Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Axon Medchem Piperlongumine Product Portfolio
6.21.5 Axon Medchem Recent Developments/Updates
6.22 Dalton Research Molecules
6.22.1 Dalton Research Molecules Corporation Information
6.22.2 Dalton Research Molecules Piperlongumine Description and Business Overview
6.22.3 Dalton Research Molecules Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Dalton Research Molecules Piperlongumine Product Portfolio
6.22.5 Dalton Research Molecules Recent Developments/Updates
6.23 ChemScene
6.23.1 ChemScene Corporation Information
6.23.2 ChemScene Piperlongumine Description and Business Overview
6.23.3 ChemScene Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 ChemScene Piperlongumine Product Portfolio
6.23.5 ChemScene Recent Developments/Updates
6.24 CSNpharm
6.24.1 CSNpharm Corporation Information
6.24.2 CSNpharm Piperlongumine Description and Business Overview
6.24.3 CSNpharm Piperlongumine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 CSNpharm Piperlongumine Product Portfolio
6.24.5 CSNpharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piperlongumine Industry Chain Analysis
7.2 Piperlongumine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piperlongumine Production Mode & Process
7.4 Piperlongumine Sales and Marketing
7.4.1 Piperlongumine Sales Channels
7.4.2 Piperlongumine Distributors
7.5 Piperlongumine Customers
8 Piperlongumine Market Dynamics
8.1 Piperlongumine Industry Trends
8.2 Piperlongumine Market Drivers
8.3 Piperlongumine Market Challenges
8.4 Piperlongumine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Piperlongumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Piperlongumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Piperlongumine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Piperlongumine Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Piperlongumine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Piperlongumine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Piperlongumine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Piperlongumine Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Piperlongumine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Piperlongumine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Piperlongumine, Product Type & Application
Table 12. Global Key Manufacturers of Piperlongumine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Piperlongumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piperlongumine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Piperlongumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Piperlongumine Sales by Region (2019-2024) & (Tons)
Table 18. Global Piperlongumine Sales Market Share by Region (2019-2024)
Table 19. Global Piperlongumine Sales by Region (2025-2030) & (Tons)
Table 20. Global Piperlongumine Sales Market Share by Region (2025-2030)
Table 21. Global Piperlongumine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Piperlongumine Revenue Market Share by Region (2019-2024)
Table 23. Global Piperlongumine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Piperlongumine Revenue Market Share by Region (2025-2030)
Table 25. North America Piperlongumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Piperlongumine Sales by Country (2019-2024) & (Tons)
Table 27. North America Piperlongumine Sales by Country (2025-2030) & (Tons)
Table 28. North America Piperlongumine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Piperlongumine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Piperlongumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Piperlongumine Sales by Country (2019-2024) & (Tons)
Table 32. Europe Piperlongumine Sales by Country (2025-2030) & (Tons)
Table 33. Europe Piperlongumine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Piperlongumine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Piperlongumine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Piperlongumine Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Piperlongumine Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Piperlongumine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Piperlongumine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Piperlongumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Piperlongumine Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Piperlongumine Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Piperlongumine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Piperlongumine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Piperlongumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Piperlongumine Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Piperlongumine Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Piperlongumine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Piperlongumine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Piperlongumine Sales (Tons) by Type (2019-2024)
Table 51. Global Piperlongumine Sales (Tons) by Type (2025-2030)
Table 52. Global Piperlongumine Sales Market Share by Type (2019-2024)
Table 53. Global Piperlongumine Sales Market Share by Type (2025-2030)
Table 54. Global Piperlongumine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Piperlongumine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Piperlongumine Revenue Market Share by Type (2019-2024)
Table 57. Global Piperlongumine Revenue Market Share by Type (2025-2030)
Table 58. Global Piperlongumine Price (US$/Ton) by Type (2019-2024)
Table 59. Global Piperlongumine Price (US$/Ton) by Type (2025-2030)
Table 60. Global Piperlongumine Sales (Tons) by Application (2019-2024)
Table 61. Global Piperlongumine Sales (Tons) by Application (2025-2030)
Table 62. Global Piperlongumine Sales Market Share by Application (2019-2024)
Table 63. Global Piperlongumine Sales Market Share by Application (2025-2030)
Table 64. Global Piperlongumine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Piperlongumine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Piperlongumine Revenue Market Share by Application (2019-2024)
Table 67. Global Piperlongumine Revenue Market Share by Application (2025-2030)
Table 68. Global Piperlongumine Price (US$/Ton) by Application (2019-2024)
Table 69. Global Piperlongumine Price (US$/Ton) by Application (2025-2030)
Table 70. Didu Corporation Information
Table 71. Didu Description and Business Overview
Table 72. Didu Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Didu Piperlongumine Product
Table 74. Didu Recent Developments/Updates
Table 75. Aikon Corporation Information
Table 76. Aikon Description and Business Overview
Table 77. Aikon Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Aikon Piperlongumine Product
Table 79. Aikon Recent Developments/Updates
Table 80. YuanYe Corporation Information
Table 81. YuanYe Description and Business Overview
Table 82. YuanYe Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. YuanYe Piperlongumine Product
Table 84. YuanYe Recent Developments/Updates
Table 85. TargetMol Corporation Information
Table 86. TargetMol Description and Business Overview
Table 87. TargetMol Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. TargetMol Piperlongumine Product
Table 89. TargetMol Recent Developments/Updates
Table 90. Bide Pharmatech Corporation Information
Table 91. Bide Pharmatech Description and Business Overview
Table 92. Bide Pharmatech Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Bide Pharmatech Piperlongumine Product
Table 94. Bide Pharmatech Recent Developments/Updates
Table 95. Macklin Corporation Information
Table 96. Macklin Description and Business Overview
Table 97. Macklin Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Macklin Piperlongumine Product
Table 99. Macklin Recent Developments/Updates
Table 100. Solarbio Corporation Information
Table 101. Solarbio Description and Business Overview
Table 102. Solarbio Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Solarbio Piperlongumine Product
Table 104. Solarbio Recent Developments/Updates
Table 105. DaoLan Corporation Information
Table 106. DaoLan Description and Business Overview
Table 107. DaoLan Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. DaoLan Piperlongumine Product
Table 109. DaoLan Recent Developments/Updates
Table 110. Beijing Jingming Corporation Information
Table 111. Beijing Jingming Description and Business Overview
Table 112. Beijing Jingming Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Beijing Jingming Piperlongumine Product
Table 114. Beijing Jingming Recent Developments/Updates
Table 115. Shanghai Xianding Corporation Information
Table 116. Shanghai Xianding Description and Business Overview
Table 117. Shanghai Xianding Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Shanghai Xianding Piperlongumine Product
Table 119. Shanghai Xianding Recent Developments/Updates
Table 120. Chengdu Gechun Corporation Information
Table 121. Chengdu Gechun Description and Business Overview
Table 122. Chengdu Gechun Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Chengdu Gechun Piperlongumine Product
Table 124. Chengdu Gechun Recent Developments/Updates
Table 125. Shanghai AcmecBiochemical Corporation Information
Table 126. Shanghai AcmecBiochemical Description and Business Overview
Table 127. Shanghai AcmecBiochemical Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Shanghai AcmecBiochemical Piperlongumine Product
Table 129. Shanghai AcmecBiochemical Recent Developments/Updates
Table 130. Cool Pharm Corporation Information
Table 131. Cool Pharm Description and Business Overview
Table 132. Cool Pharm Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Cool Pharm Piperlongumine Product
Table 134. Cool Pharm Recent Developments/Updates
Table 135. GLR Innovations Corporation Information
Table 136. GLR Innovations Description and Business Overview
Table 137. GLR Innovations Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 138. GLR Innovations Piperlongumine Product
Table 139. GLR Innovations Recent Developments/Updates
Table 140. ABCR GmBH Corporation Information
Table 141. ABCR GmBH Description and Business Overview
Table 142. ABCR GmBH Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 143. ABCR GmBH Piperlongumine Product
Table 144. ABCR GmBH Recent Developments/Updates
Table 145. Chem-Impex International Corporation Information
Table 146. Chem-Impex International Description and Business Overview
Table 147. Chem-Impex International Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 148. Chem-Impex International Piperlongumine Product
Table 149. Chem-Impex International Recent Developments/Updates
Table 150. Cayman Chemical Corporation Information
Table 151. Cayman Chemical Description and Business Overview
Table 152. Cayman Chemical Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 153. Cayman Chemical Piperlongumine Product
Table 154. Cayman Chemical Recent Developments/Updates
Table 155. Apollo Scientific Corporation Information
Table 156. Apollo Scientific Description and Business Overview
Table 157. Apollo Scientific Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 158. Apollo Scientific Piperlongumine Product
Table 159. Apollo Scientific Recent Developments/Updates
Table 160. Matrix Scientific Corporation Information
Table 161. Matrix Scientific Description and Business Overview
Table 162. Matrix Scientific Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 163. Matrix Scientific Piperlongumine Product
Table 164. Matrix Scientific Recent Developments/Updates
Table 165. Tocris Bioscience Corporation Information
Table 166. Tocris Bioscience Description and Business Overview
Table 167. Tocris Bioscience Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 168. Tocris Bioscience Piperlongumine Product
Table 169. Tocris Bioscience Recent Developments/Updates
Table 170. Axon Medchem Corporation Information
Table 171. Axon Medchem Description and Business Overview
Table 172. Axon Medchem Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 173. Axon Medchem Piperlongumine Product
Table 174. Axon Medchem Recent Developments/Updates
Table 175. Dalton Research Molecules Corporation Information
Table 176. Dalton Research Molecules Description and Business Overview
Table 177. Dalton Research Molecules Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 178. Dalton Research Molecules Piperlongumine Product
Table 179. Dalton Research Molecules Recent Developments/Updates
Table 180. ChemScene Corporation Information
Table 181. ChemScene Description and Business Overview
Table 182. ChemScene Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 183. ChemScene Piperlongumine Product
Table 184. ChemScene Recent Developments/Updates
Table 185. CSNpharm Corporation Information
Table 186. CSNpharm Description and Business Overview
Table 187. CSNpharm Piperlongumine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 188. CSNpharm Piperlongumine Product
Table 189. CSNpharm Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Piperlongumine Distributors List
Table 193. Piperlongumine Customers List
Table 194. Piperlongumine Market Trends
Table 195. Piperlongumine Market Drivers
Table 196. Piperlongumine Market Challenges
Table 197. Piperlongumine Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Piperlongumine
Figure 2. Global Piperlongumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Piperlongumine Market Share by Type in 2023 & 2030
Figure 4. 95% Purity Product Picture
Figure 5. 97% Purity Product Picture
Figure 6. 98% Purity Product Picture
Figure 7. Global Piperlongumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Piperlongumine Market Share by Application in 2023 & 2030
Figure 9. Medical
Figure 10. Health Products
Figure 11. Global Piperlongumine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Piperlongumine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Piperlongumine Sales (2019-2030) & (Tons)
Figure 14. Global Piperlongumine Average Price (US$/Ton) & (2019-2030)
Figure 15. Piperlongumine Report Years Considered
Figure 16. Piperlongumine Sales Share by Manufacturers in 2023
Figure 17. Global Piperlongumine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Piperlongumine Players: Market Share by Revenue in 2023
Figure 19. Piperlongumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Piperlongumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Piperlongumine Sales Market Share by Country (2019-2030)
Figure 22. North America Piperlongumine Revenue Market Share by Country (2019-2030)
Figure 23. United States Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Piperlongumine Sales Market Share by Country (2019-2030)
Figure 26. Europe Piperlongumine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Piperlongumine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Piperlongumine Revenue Market Share by Region (2019-2030)
Figure 34. China Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Piperlongumine Sales Market Share by Country (2019-2030)
Figure 42. Latin America Piperlongumine Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Piperlongumine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Piperlongumine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Piperlongumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Piperlongumine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Piperlongumine by Type (2019-2030)
Figure 54. Global Piperlongumine Price (US$/Ton) by Type (2019-2030)
Figure 55. Global Sales Market Share of Piperlongumine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Piperlongumine by Application (2019-2030)
Figure 57. Global Piperlongumine Price (US$/Ton) by Application (2019-2030)
Figure 58. Piperlongumine Value Chain
Figure 59. Piperlongumine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
